All filters
Abstracts
A PBPK modelling approach to simulate the rifampicin-moxifloxacin drug-drug interaction in TB patients
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019
Abstracts
An assay to measure drug tolerance of M. tuberculosis in the caseous center of pulmonary lesions
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019
Abstracts
Levofloxacin target attainment analysis in MDR-TB patients: time is ripe for proactive TDM
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019
Abstracts
Population Pharmacokinetics of Linezolid in TB Patients: Dosing Regimens Simulation and Target Attainment Analysis
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019
Abstracts
PK-PD of isoniazid given at different doses among patients with MDR-TB with INH resistance mediated by inhA mutations: modeling results from ACTG A5312.
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019
Abstracts
The OptiRIF study: pharmacokinetics of high-dose rifampicin in children
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019
Abstracts
Ethionamide population pharmacokinetic model and Monte Carlo Simulation in patients with multidrug-resistant tuberculosis
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019
Abstracts
Increased bactericidal activity but dose-limiting tolerability at 50 mg/kg rifampicin
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019
Abstracts
Pharmacogenetics and pharmacokinetics of first-line anti-tuberculosis drugs in the HIRIF trial
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019
Abstracts
Pharmacokinetics and Early Bactericidal Activity of Meropenem (with Amoxicillin/Clavulanate), With and Without Rifampicin, for Drug-Susceptible TB
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019
Abstracts
Co-administration of pretomanid with rifampin or rifabutin among patients with pulmonary TB: interim PK results from “Assessing Pretomanid for Tuberculosis” (APT) trial
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019
Abstracts
Relationship between plasma and intracellular concentrations of bedaquiline and its M2 metabolite in South African patients with drug-resistant TB
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019
Abstracts
Evaluating hepatotoxicity of bedaquiline treatment in multi-drug resistant tuberculosis patients
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019
Abstracts
Abstract Book - CEE Meeting on Viral Hepatitis and HIV 2020
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2020
Abstracts
Abstract Book - European Meeting on HIV & Hepatitis 2020
Presented at:
European Meeting on HIV & Hepatitis 2020
Abstracts
Reinfection With Hepatitis C Virus: Clinical Case Reports And Literature Review
L. Jancoriene, G. Ulianskaite Reviews in Antiviral Therapy & Infectious Diseases 3, 2020
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2020
Abstracts
Characteristics Of Women Diagnosed With HIV In The WHO European Region And Predictors Of Late Diagnosis
O. Mårdh Reviews in Antiviral Therapy & Infectious Diseases 3, 2020
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2020
Abstracts
A Pilot Study Of The Acceptability And Feasibility Of HCV Self-Testing Among Key Populations In Georgia
S. Shilton Reviews in Antiviral Therapy & Infectious Diseases 3, 2020
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2020
Abstracts
Evidence Of Experience In Community-Based HCV Treatment Among HIV/HCV Co-Infected PWIDs In Ukraine
Z. Islam Reviews in Antiviral Therapy & Infectious Diseases 3, 2020
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2020
Abstracts
Determination Of Drug Resistance Of Hepatitis C Virus To NS5A Protein Inhibitors As A New Approach To Personalized Medicine
E. Gasich Reviews in Antiviral Therapy & Infectious Diseases 3, 2020
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2020
Abstracts
Quality Of Lives Of PLWHA From Baylor Clinic In Constanta, Romania Decreased During The COVID-19 Pandemic
A. M. Schweitzer Reviews in Antiviral Therapy & Infectious Diseases 3, 2020
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2020
Abstracts
Coinfection With Hepatitis Viruses In Patients With HIV Infection
O. Sandulescu Reviews in Antiviral Therapy & Infectious Diseases 3, 2020
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2020